サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1749707

ソフトジェルカプセルの世界市場：材料タイプ別、由来別、用途別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Global Softgel Capsules Market Assessment, By Material Type, By Source, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 229 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.92円
ソフトジェルカプセルの世界市場：材料タイプ別、由来別、用途別、エンドユーザー別、地域別、機会、予測、2018年～2032年
出版日: 2025年06月17日
発行: Market Xcel - Markets and Data
ページ情報: 英文 229 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ソフトジェルカプセルの世界市場は、2025～2032年の予測期間中にCAGR 5.45％を記録し、2024年の23億4,000万米ドルから2032年には35億8,000万米ドルに成長すると予測されています。市場発展の背景には、製薬業界の急速な拡大、研究開発活動への投資の増加、新製品や新技術の導入への注目の高まりがあります。ソフトジェルカプセルは通常、飲み込みやすさ、バイオアベイラビリティの向上、不快な臭いや風味を隠すことができる機能により好まれています。オメガ3脂肪酸、ビタミン、漢方薬などの食品サプリメントに対する顧客需要の増加も、市場の主な促進要因です。

さらに、高齢化社会における健康志向の高まりや、予防医療への関心の高まりも市場の拡大を支えています。ヒドロキシプロピルメチルセルロースやタピオカデンプン由来のカプセルを含む、植物由来の代替品などの技術革新への投資は、ベジタリアン代替品への要求の高まりに対応するために行われています。一方、製造工程における技術の進歩は、製品の多様性を高め、生産効率を向上させるのに役立っています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界のソフトジェルカプセル市場の展望、2018年～2032年

  • 市場規模分析と予測
    • 金額別
  • 市場シェア分析と予測
    • 材料タイプ別
      • ゼラチン/動物由来
      • 非動物由来
    • 由来別
      • 豚
      • 牛
      • その他
    • 用途別
      • 制酸剤・整腸剤
      • 抗貧血剤
      • 抗炎症薬
      • 抗生物質・抗菌薬
      • 咳止め・風邪薬
      • 健康サプリメント
      • ビタミン・栄養補助食品
    • エンドユーザー別
      • 製薬企業
      • 栄養補助食品企業
      • 化粧品企業
      • 契約製造組織
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東・アフリカ
    • 企業別の市場シェア分析（上位5社・その他 - 金額別、2024年）
  • 2024年の市場マップ分析
    • 材料タイプ別
    • 由来別
    • 用途別
    • エンドユーザー別
    • 地域別

第6章 北米のソフトジェルカプセル市場の展望、2018年～2032年

  • 市場規模分析と予測
    • 金額別
  • 市場シェア分析と予測
    • 材料タイプ別
      • ゼラチン/動物由来
      • 非動物由来
    • 由来別
      • 豚
      • 牛
      • その他
    • 用途別
      • 制酸剤・整腸剤
      • 抗貧血剤
      • 抗炎症薬
      • 抗生物質・抗菌薬
      • 咳止め・風邪薬
      • 健康サプリメント
      • ビタミン・栄養補助食品
    • エンドユーザー別
      • 製薬企業
      • 栄養補助食品企業
      • 化粧品企業
      • 契約製造組織
    • 国別シェア
      • 米国
      • カナダ
      • メキシコ
  • 国別市場評価
    • 米国のソフトジェルカプセル市場の展望、2018年～2032年
      • 市場規模分析と予測
      • 市場シェア分析と予測
    • カナダ
    • メキシコ

第7章 欧州のソフトジェルカプセル市場の展望、2018年～2032年

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • ポーランド

第8章 アジア太平洋のソフトジェルカプセル市場の展望、2018年～2032年

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第9章 南米のソフトジェルカプセル市場の展望、2018年～2032年

  • ブラジル
  • アルゼンチン

第10章 中東・アフリカのソフトジェルカプセル市場の展望、2018年～2032年

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ
  • イスラエル

第11章 需要供給分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

  • 市場促進要因
  • 市場の課題

第17章 市場動向と発展

第18章 規制枠組みとイノベーション

  • 臨床試験
  • 規制当局の承認

第19章 特許の情勢

第20章 ケーススタディ

第21章 競合情勢

  • 市場リーダー上位5社の競合マトリックス
  • 上位5社のSWOT分析
  • 上位10社の主要企業の情勢
    • Thermo Fisher Scientific Inc.
    • EyePoint Pharmaceuticals, Inc.
    • Catalent, Inc.
    • ProCaps Laboratories, LLC
    • Soft Gel Technologies, Inc.
    • Gelatin, Inc.
    • Narmada Gelatines Limited
    • Xiamen Gelken Gelatin Co., Ltd.
    • Aenova Group
    • Sirio Pharma Co., Ltd.

第22章 戦略的提言

第23章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 3. Global Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 4. Global Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 5. Global Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Softgel Capsules Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 9. North America Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 10. North America Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 11. North America Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 15. United States Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 16. United States Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 17. United States Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 20. Canada Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 21. Canada Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 22. Canada Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 25. Mexico Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 26. Mexico Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 27. Mexico Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 30. Europe Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 31. Europe Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 32. Europe Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 36. Germany Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 37. Germany Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 38. Germany Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 41. France Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 42. France Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 43. France Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 46. Italy Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 47. Italy Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 48. Italy Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 51. United Kingdom Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 52. United Kingdom Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 53. United Kingdom Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 56. Russia Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 57. Russia Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 58. Russia Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 61. Netherlands Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 62. Netherlands Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 63. Netherlands Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 66. Spain Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 67. Spain Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 68. Spain Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 71. Turkey Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 72. Turkey Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 73. Turkey Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 76. Poland Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 77. Poland Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 78. Poland Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 81. South America Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 82. South America Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 83. South America Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 87. Brazil Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 88. Brazil Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 89. Brazil Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 92. Argentina Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 93. Argentina Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 94. Argentina Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 97. Asia-Pacific Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 98. Asia-Pacific Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 99. Asia- Pacific Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 101. India Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 103. India Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 104. India Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 105. India Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 108. China Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 109. China Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 110. China Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 113. Japan Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 114. Japan Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 115. Japan Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 118. Australia Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 119. Australia Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 120. Australia Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 123. Vietnam Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 124. Vietnam Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 125. Vietnam Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 128. South Korea Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 129. South Korea Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 130. South Korea Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 133. Indonesia Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 134. Indonesia Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 135. Indonesia Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 138. Philippines Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 139. Philippines Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 140. Philippines Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 143. Middle East & Africa Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 144. Middle East & Africa Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 145. Middle East & Africa Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 149. Saudi Arabia Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 150. Saudi Arabia Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 151. Saudi Arabia Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 154. UAE Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 155. UAE Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 156. UAE Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 159. South Africa Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 160. South Africa Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 161. South Africa Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Material Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX13355

Global softgel capsules market is projected to witness a CAGR of 5.45% during the forecast period 2025-2032, growing from USD 2.34 billion in 2024 to USD 3.58 billion in 2032. The growth of the market can be attributed to the rapid expansion of the pharmaceutical industry, increasing investments in research and development activities, and a growing focus on the introduction of novel products and technologies. Softgel capsules are usually preferred due to their ease of swallowing, improved bioavailability, and the ability to mask unpleasant odors and flavors. Increasing customer demand for food supplements such as omega-3 fatty acids, vitamins, and herbal medication is also a major market driver.

Additionally, the market's expansion is also supported by the increasing health consciousness among the aging population and the increasing emphasis on preventive healthcare. Investments in innovations such as plant-based alternatives, including capsules derived from hydroxypropyl methylcellulose and tapioca starch, are being made to address the growing requirement for vegetarian alternatives. Meanwhile, technological advancements in manufacturing processes are aiding in increasing product diversity and improving production efficiency.

Novel Launches Bolster Market Growth

Key manufacturers and leading players in the market are increasingly focusing on launching new formulations to cater to the evolving industry demands and requirements of consumers. Companies across the globe are increasingly focusing on developing vegan and plant-based softgel capsules to appeal to health and environmentally conscious consumers seeking alternatives to traditional capsules. For instance, in May 2024, Roquette Group launched LYCAGEL Flex hydroxypropyl pea starch premix for pharmaceutical and nutraceutical softgel capsules. The premix aids manufacturers in customizing formulations by selecting optimal plasticizer combinations, catering to the diverse requirements of both producers and end-users. Additionally, LYCAGEL Flex addresses the various challenges associated with gelatin-based capsules, including interactions with specific fill types, molecular crosslinking, and sensitivity to heat and moisture.

Moreover, the launch of new products with advanced encapsulation technologies, including the development of delayed-release and enteric-coated softgels are improving the bioavailability and therapeutic efficacy of the medications. These innovations allow for more effective delivery of active ingredients, particularly for sensitive compounds that require protection from gastric acid, increasing physician confidence in the product and bolstering demand.

Rising Collaborations Support Market Expansion

The increase in collaborations between leading pharmaceutical companies to support research and development activities is one of the major drivers of the market, as such efforts allow them to innovate novel therapeutic solutions and leverage one another's strengths, including market reach and technical expertise.

For instance, in February 2025, Jupiter Neurosciences Inc. partnered with Catalent Pharma Solutions LLC to produce JOTROL softgel capsules to support the former's upcoming Phase 2a clinical trial in Parkinson's disease. The trial is going to evaluate the pharmacokinetics/pharmacodynamics, safety, and tolerability of JOTROL over three months. Such collaborations are expected to bolster the availability of novel treatment options for neurodegenerative diseases, propelling the requirement for softgel capsules and providing lucrative growth opportunities for the market.

Such collaborations are also allowing the development of novel softgel products that meet the previously unmet requirements of the patient population. By pooling resources pharmaceutical companies are also able to improve the accessibility and affordability of the end product, allowing them to capture a broader share of the market.

Nutraceutical Companies Account for Significant Share of the Market

The increasing adoption of preventive healthcare approaches is resulting in higher consumption of herbal supplements, omega-3 fatty acids, vitamins, and minerals, which are often formulated in softgel form. These capsules are preferred for nutraceutical applications due to the ease of swallowing offered by these capsules, along with high bioavailability. They also improve the stability of fat-soluble and oil-based nutrients, further increasing their preference for delivering herbal and nutritional ingredients as compared to other tablets and powders.

Additionally, the growing popularity of health and wellness trends, including cognitive functions, gut health, and immunity-boosting supplements, has further increased the demand for softgel capsules. To meet this growing demand, leading nutraceutical companies are increasingly focusing on mergers and acquisitions, new product launches, and research and development activities.

Moreover, the rising investments in the nutraceutical CDMOs are also supporting the segment's growth. For instance, in March 2025, Tirupati Medicare Ltd. received an investment of approximately USD 122 million, allowing them to expand their product portfolio and manufacturing capabilities. Additionally, the investment is also expected to support Tirupati in implementing various inorganic growth strategies and help drive sales.

North America Region Holds Major Market Share

The dominance of the region can be attributed to high consumer awareness of health and wellness products, driven by the growing demand for dietary supplements and nutraceuticals. The United States dominates the North American market, supported by an aging population and increasing demand for supplements targeting chronic disease prevention. According to the estimates of the Population Reference Bureau, the number of individuals aged 65 and above is estimated to increase to 82 million by 2050 from 58 million in 2022. The presence of major pharmaceutical and nutraceutical manufacturers in North America contributes significantly to market growth. Companies in the region invest heavily in research and development to expand their product portfolios, including innovations in non-gelatin and plant-based capsules to cater to diverse consumer preferences. Additionally, advanced production technologies and robust distribution networks, including pharmacies, supermarkets, and online platforms, ensure widespread accessibility of softgel capsules. Moreover, the region benefits from a strong regulatory framework that ensures high-quality production standards, enhancing consumer trust. These factors collectively position North America as a dominant player in the global softgel capsules market.

Future Market Scenario (2025-2032F)

As per the global softgel capsules market analysis, the market's demand is expected to increase significantly in the coming years due to the growing requirement for dietary supplements as health consciousness among consumers rises. Some of the innovations and advancements in the market would include advancements in encapsulation technologies, including nano-emulsion formulations and sustained release. As the preference for sustainability, convenience, and efficacy increases, the market is expected to encounter lucrative growth opportunities.

Meanwhile, the key players in the industry are expected to focus on the expansion of manufacturing facilities, new product launches, and strategic acquisitions to stay competitive in this industry and hold their position.

Key Players Landscape and Outlook

The leading players across the globe are actively investing in launching new products with enhanced features, providing lucrative growth opportunities. For instance, in March 2024, LEE HEALTH DOMAIN (I) PVT. LTD., an Indian nutraceutical company, launched Lyphosterol, a natural polypill supplement for heart care. The soft gel capsule contains bioactive compounds from aged garlic extract, gamma oryzanol, phytosterol, lycopene, nano curcumin, fenugreek, and piperine. These compounds effectively balance cholesterol and triglyceride levels, remove soft plaque in arteries, stabilize irregular heartbeats, protect against free radicals, and reduce heart disease risk.

Additionally, the companies are also engaging in mergers and acquisitions to expand their product portfolios, improve their manufacturing capabilities, and enhance their reach. For instance, in March 2023, Darling Ingredients Inc. completed its acquisition of Gelnex, Inc., a Brazilian gelatin and collagen producer. The acquisition includes five facilities in South America and one in the United States, providing Darling Ingredients with the capacity to produce 46,000 metric tons of gelatin and collagen every year.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Softgel Capsules Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Material Type
      • 5.2.1.1. Gelatin/Animal-based
      • 5.2.1.2. Non-Animal-based
    • 5.2.2. By Source
      • 5.2.2.1. Porcine
      • 5.2.2.2. Bovine
      • 5.2.2.3. Others
    • 5.2.3. By Application
      • 5.2.3.1. Antacid and Anti-Flatulent Preparations
      • 5.2.3.2. Anti-Anemic Preparations
      • 5.2.3.3. Anti-Inflammatory Drugs
      • 5.2.3.4. Antibiotic and Antibacterial Drugs
      • 5.2.3.5. Cough and Cold Preparations
      • 5.2.3.6. Health Supplements
      • 5.2.3.7. Vitamin and Dietary Supplements
    • 5.2.4. By End-user
      • 5.2.4.1. Pharmaceutical Companies
      • 5.2.4.2. Nutraceutical Companies
      • 5.2.4.3. Cosmeceutical Companies
      • 5.2.4.4. Contract Manufacturing Organizations
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia-Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East and Africa
    • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Material Type
    • 5.3.2. By Source
    • 5.3.3. By Application
    • 5.3.4. By End-user
    • 5.3.5. By Region

6. North America Softgel Capsules Market Outlook, 2018-2032F*

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Material Type
      • 6.2.1.1. Gelatin/Animal-based
      • 6.2.1.2. Non-Animal-based
    • 6.2.2. By Source
      • 6.2.2.1. Porcine
      • 6.2.2.2. Bovine
      • 6.2.2.3. Others
    • 6.2.3. By Application
      • 6.2.3.1. Antacid and Anti-flatulent Preparations
      • 6.2.3.2. Anti-anemic Preparations
      • 6.2.3.3. Anti-inflammatory Drugs
      • 6.2.3.4. Antibiotic and Antibacterial Drugs
      • 6.2.3.5. Cough and Cold Preparations
      • 6.2.3.6. Health Supplements
      • 6.2.3.7. Vitamin and Dietary Supplements
    • 6.2.4. By End-user
      • 6.2.4.1. Pharmaceutical Companies
      • 6.2.4.2. Nutraceutical Companies
      • 6.2.4.3. Cosmeceutical Companies
      • 6.2.4.4. Contract Manufacturing Organizations
    • 6.2.5. By Country Share
      • 6.2.5.1. United States
      • 6.2.5.2. Canada
      • 6.2.5.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Softgel Capsules Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Material Type
          • 6.3.1.2.1.1. Gelatin/ Animal-based
          • 6.3.1.2.1.2. Non-Animal-based
        • 6.3.1.2.2. By Source
          • 6.3.1.2.2.1. Porcine
          • 6.3.1.2.2.2. Bovine
          • 6.3.1.2.2.3. Others
        • 6.3.1.2.3. By Application
          • 6.3.1.2.3.1. Antacid and Anti-Flatulent Preparations
          • 6.3.1.2.3.2. Anti-Anemic Preparations
          • 6.3.1.2.3.3. Anti-Inflammatory Drugs
          • 6.3.1.2.3.4. Antibiotic and Antibacterial Drugs
          • 6.3.1.2.3.5. Cough and Cold Preparations
          • 6.3.1.2.3.6. Health Supplements
          • 6.3.1.2.3.7. Vitamin and Dietary Supplements
        • 6.3.1.2.4. By End-user
          • 6.3.1.2.4.1. Pharmaceutical Companies
          • 6.3.1.2.4.2. Nutraceutical Companies
          • 6.3.1.2.4.3. Cosmeceutical Companies
          • 6.3.1.2.4.4. Contract Manufacturing Organizations
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Softgel Capsules Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Poland

8. Asia-Pacific Softgel Capsules Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Softgel Capsules Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Softgel Capsules Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa
  • 10.4. Israel

11. Demand Supply Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Thermo Fisher Scientific Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. EyePoint Pharmaceuticals, Inc.
    • 21.3.3. Catalent, Inc.
    • 21.3.4. ProCaps Laboratories, LLC
    • 21.3.5. Soft Gel Technologies, Inc.
    • 21.3.6. Gelatin, Inc.
    • 21.3.7. Narmada Gelatines Limited
    • 21.3.8. Xiamen Gelken Gelatin Co., Ltd.
    • 21.3.9. Aenova Group
    • 21.3.10. Sirio Pharma Co., Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer